Skip to content
Sharism- Lifestyle
Author:
Biovica International
Biovica Receives First Work Order Under Expanded Master Services Agreement with Leading Global Pharmaceutical Customer
July 20, 2026
Biovica Expands Japanese Patent Protection in Immuno-Oncology
July 16, 2026
Biovica Receives Ninth Work Order From a Leading Global Pharmaceutical Customer
July 14, 2026
Biovica Appoints Maria Ekdahl as New Chief Financial Officer
July 7, 2026
Correction: Biovica appoints Maria Ekdahl as new Chief Financial Officer
July 7, 2026
Biovica Expands Master Services Agreement with a Current Customer, a Leading Global Pharmaceutical Company, to Support Next-Generation Oncology Development
July 7, 2026
Biovica Granted Japanese Patent for Immuno-Oncology
July 1, 2026
Biovica Refocuses US Commercial Strategy and Terminates Agreement with Tempus AI
June 30, 2026
Correction: Biovica Refocuses US Commercial Strategy and Terminates Agreement with Tempus AI
June 30, 2026
Biovica International AB – Annual Report for The Financial Year 2025/2026 Published
June 30, 2026
←
Previous Page
1
2
3
Next Page
→